Exscientia (EXAI)
(Delayed Data from NSDQ)
$5.28 USD
-0.03 (-0.56%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $5.30 +0.02 (0.38%) 6:32 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EXAI 5.28 -0.03(-0.56%)
Will EXAI be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for EXAI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EXAI
Harrow (HROW) Surges 8.4%: Is This an Indication of Further Gains?
Amazon (AMZN) Plunges 19.1% in a Month: Should You Buy the Dip?
EXAI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amazon (AMZN) Expands AWS Clientele With Exscientia Deal
How Much Upside is Left in Exscientia (EXAI)? Wall Street Analysts Think 61.43%
Can Exscientia (EXAI) Climb 57.17% to Reach the Level Wall Street Analysts Expect?
Other News for EXAI
Exscientia Plc Enhances Board Collaboration with Recursion
EXAI Crosses Above Key Moving Average Level
Morgan Stanley Sticks to Its Hold Rating for Exscientia Plc (EXAI)
TD Cowen Sticks to Its Hold Rating for Exscientia Plc (EXAI)
Exscientia to receive $15M in milestones for Sanofi collaboration